Exhibit 107
Calculation of Filing Fee Tables
FORM S-1
(Form Type)
COEPTIS THERAPEUTICS HOLDINGS, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered |
Maximum Aggregate Offering Price (1) |
Amount of Registration Fee (2) | |
| Newly Registered Securities | ||||||
| Fees to Be Paid |
||||||
| Equity | Series A Warrants (3) | 457(g) | ||||
| Series B Warrants (3) | 457(g) | |||||
| Equity | Shares of Common Stock, par value $0.0001 per share, issuable upon exercise of Series A Warrants | 457(o) | $750,000 | $82.65 | ||
| Equity | Shares of Common Stock, par value $0.0001 per share, issuable upon exercise of Series B Warrants | 457(o) | $750,000 | $82.65 | ||
| Total Offering Amounts | $1,500,000 | $165.30 | ||||
| Total Fees Previously Paid | $0 | |||||
| Total Fee Offsets | $0 | |||||
| Net Fee Due | $165.30 | |||||
| (1) | In accordance with Rule 462(b) under the Securities Act of 1933, as amended (the Securities Act”), an additional amount of securities having a proposed maximum aggregate offering price of $1,500,000 is hereby registered. |
| (2) | The registrant previously registered securities with a proposed maximum aggregate offering price of (i) $12,300,000 on a registration statement on Form S-1, as amended (File No. 333-269782) (the “Prior Registration Statement”), which was declared effective by the Securities and Exchange Commission on June 13, 2023 and (ii) and an additional $922,500 on an MEF Form S-1 (File No. 333-272629) of the Company that was filed with the Securities and Exchange Commission on June 13, 2023 (the “MEF Registration Statement”). |
|
(3)
|
No fee pursuant to Rule 457(g) of the Securities Act. |